Loading clinical trials...
Loading clinical trials...
A Prospective Multicenter Randomized Controlled Clinical Study to Investigate the Safety and Effectiveness of RES® (Regenerative Epidermal Suspension) Prepared With the RECELL® Device Compared to Standard of Care Dressings for Treatment of Partial-thickness Burns in Infants, Children and Adolescents (Aged 1-16 Years)
Conditions
Interventions
RES (Regenerative Epidermal Suspension) prepared using the RECELL® Autologous Cell Harvesting Device
Mepilex® Ag Wound Dressing
+1 more
Locations
9
United States
Arizona Burn Center / Valleywise Health
Phoenix, Arizona, United States
University of South Florida Tampa General Hospital
Tampa, Florida, United States
University Medical Center New Orleans
New Orleans, Louisiana, United States
University of North Carolina
Chapel Hill, North Carolina, United States
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, United States
Saint Christopher's Hospital for Children
Philadelphia, Pennsylvania, United States
Start Date
March 3, 2020
Primary Completion Date
June 23, 2021
Completion Date
June 3, 2022
Last Updated
July 30, 2024
NCT06596434
NCT06814717
NCT07277166
NCT06379724
NCT06987981
NCT06559501
Lead Sponsor
Avita Medical
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions